Exact Mass: 910.4033238000001

Exact Mass Matches: 910.4033238000001

Found 14 metabolites which its exact mass value is equals to given mass value 910.4033238000001, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

A6 Peptide

4-({[1-(1-{2-[(2-{[(1-{6-amino-2-[(1-hydroxyethylidene)amino]hexanoyl}pyrrolidin-2-yl)(hydroxy)methylidene]amino}-1,3-dihydroxypropylidene)amino]-3-hydroxypropanoyl}pyrrolidine-2-carbonyl)pyrrolidin-2-yl](hydroxy)methylidene}amino)-4-{[3-carboxy-1-(C-hydroxycarbonimidoyl)propyl]-C-hydroxycarbonimidoyl}butanoate

C39H62N10O15 (910.4395902)


   

demycarosyl-mithramycin SK|demycarosyl-mithramycin-SK

demycarosyl-mithramycin SK|demycarosyl-mithramycin-SK

C44H62O20 (910.3834251999999)


   
   

LPIM2 17:0

2-O-(alpha-D-Manp)-6-O-(alpha-D-Manp)-(1-heptadecanoyl-sn-glycero-3-phospho-1-myo-inositol)

C38H71O22P (910.4174395999999)


   

[3-[[3-[[3-[(5E,7Z,9Z,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxy-2-hydroxypropyl] (7E,9E,11Z,13E,15E,17Z)-icosa-7,9,11,13,15,17-hexaenoate

[3-[[3-[[3-[(5E,7Z,9Z,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxy-2-hydroxypropyl] (7E,9E,11Z,13E,15E,17Z)-icosa-7,9,11,13,15,17-hexaenoate

C45H68O15P2 (910.4033238000001)


   

2-O-(alpha-D-Manp)-6-O-(alpha-D-Manp)-(1-heptadecanoyl-sn-glycero-3-phospho-1-myo-inositol)

2-O-(alpha-D-Manp)-6-O-(alpha-D-Manp)-(1-heptadecanoyl-sn-glycero-3-phospho-1-myo-inositol)

C38H71O22P (910.4174395999999)


   

Angstrom6

Angstrom6

C39H62N10O15 (910.4395902)


Angstrom6 (A6 Peptide) is an 8 amino-acid peptide derived from single-chain urokinase plasminogen activator (scuPA) and interferes with the uPA/uPAR cascade and abrogates downstream effects. Angstrom6 binds to CD44 resulting in the inhibition of migration, invasion, and metastasis of tumor cells, and the modulation of CD44-mediated cell signaling[1][2].

   

FSLLRY-NH2 (TFA)

FSLLRY-NH2 (TFA)

C41H61F3N10O10 (910.4524002)


FSLLRY-NH2 TFA is a protease-activated receptor 2 (PAR2) inhibitor[1].

   

(2s,3s)-2-{[(2s,4r,5r,6r)-4-{[(2s,4r,5r,6r)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-5-hydroxy-6-methyloxan-2-yl]oxy}-6-{[(2s,4r,5r,6r)-4-{[(2s,4r,5s,6r)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-5-hydroxy-6-methyloxan-2-yl]oxy}-8,9-dihydroxy-3-[(1s,2r)-2-hydroxy-1-methoxy-3-oxobutyl]-7-methyl-3,4-dihydro-2h-anthracen-1-one

(2s,3s)-2-{[(2s,4r,5r,6r)-4-{[(2s,4r,5r,6r)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-5-hydroxy-6-methyloxan-2-yl]oxy}-6-{[(2s,4r,5r,6r)-4-{[(2s,4r,5s,6r)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-5-hydroxy-6-methyloxan-2-yl]oxy}-8,9-dihydroxy-3-[(1s,2r)-2-hydroxy-1-methoxy-3-oxobutyl]-7-methyl-3,4-dihydro-2h-anthracen-1-one

C44H62O20 (910.3834251999999)


   

2,6-bis({4-[(4,5-dihydroxy-6-methyloxan-2-yl)oxy]-5-hydroxy-6-methyloxan-2-yl}oxy)-8,9-dihydroxy-3-(2-hydroxy-1-methoxy-3-oxobutyl)-7-methyl-3,4-dihydro-2h-anthracen-1-one

2,6-bis({4-[(4,5-dihydroxy-6-methyloxan-2-yl)oxy]-5-hydroxy-6-methyloxan-2-yl}oxy)-8,9-dihydroxy-3-(2-hydroxy-1-methoxy-3-oxobutyl)-7-methyl-3,4-dihydro-2h-anthracen-1-one

C44H62O20 (910.3834251999999)


   

2,18-dimethyl 14-[17,18-dihydroxy-4-methoxy-2,18-bis(methoxycarbonyl)-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3,5,7,14-tetraen-13-yl]-17,18-dihydroxy-4-methoxy-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3,5,7,14-tetraene-2,18-dicarboxylate

2,18-dimethyl 14-[17,18-dihydroxy-4-methoxy-2,18-bis(methoxycarbonyl)-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3,5,7,14-tetraen-13-yl]-17,18-dihydroxy-4-methoxy-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3,5,7,14-tetraene-2,18-dicarboxylate

C48H54N4O14 (910.3636344)


   

2,18-dimethyl (1s,9r,16r,17r,18r,21r)-14-[(1s,9r,16r,17r,18r,21r)-17,18-dihydroxy-4-methoxy-2,18-bis(methoxycarbonyl)-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3,5,7,14-tetraen-13-yl]-17,18-dihydroxy-4-methoxy-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3,5,7,14-tetraene-2,18-dicarboxylate

2,18-dimethyl (1s,9r,16r,17r,18r,21r)-14-[(1s,9r,16r,17r,18r,21r)-17,18-dihydroxy-4-methoxy-2,18-bis(methoxycarbonyl)-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3,5,7,14-tetraen-13-yl]-17,18-dihydroxy-4-methoxy-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3,5,7,14-tetraene-2,18-dicarboxylate

C48H54N4O14 (910.3636344)


   

2,18-dimethyl (1s,9r,16r,17r,18r,21r)-14-[(1s,9r,13s,16r,17r,18r,21r)-17,18-dihydroxy-4-methoxy-2,18-bis(methoxycarbonyl)-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3,5,7,14-tetraen-13-yl]-17,18-dihydroxy-4-methoxy-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3,5,7,14-tetraene-2,18-dicarboxylate

2,18-dimethyl (1s,9r,16r,17r,18r,21r)-14-[(1s,9r,13s,16r,17r,18r,21r)-17,18-dihydroxy-4-methoxy-2,18-bis(methoxycarbonyl)-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3,5,7,14-tetraen-13-yl]-17,18-dihydroxy-4-methoxy-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3,5,7,14-tetraene-2,18-dicarboxylate

C48H54N4O14 (910.3636344)